Generic drugmaker Watson Pharmaceuticals Inc said U.S. health regulators approved its copycat version of ViroPharma Inc's antibiotic Vancocin.
Separately, ViroPharma said the U.S. Food and Drug Administration declined its citizen petition, which was filed to prevent Watson from launching the generic version.
Shares of ViroPharma were trading down 18 percent at $23.40 in premarket.
Watson said it has started shipping the drug, which recorded sales of $332 million for the 12 months ended February 29, 2012.
ViroPharma shares closed at $28.61 on Monday on the Nasdaq.
(Reporting by Anand Basu in Bangalore; Editing by Sriraj Kalluvila)
Trending On Reuters
Psychologists and tobacco-addiction specialists, including some in world-leading laboratories in Britain, think it's now time to distinguish clearly between nicotine and smoking. The evidence shows smoking is the killer, not nicotine, they say. Full Article
Suicide bomber kills 21 at Saudi Shi'ite mosque, Islamic State claims attack Full Article